KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Current Assets (2016 - 2026)

Encompass Health (EHC) has disclosed Current Assets for 18 consecutive years, with $1.0 billion as the latest value for Q1 2026.

  • For Q1 2026, Current Assets rose 12.98% year-over-year to $1.0 billion; the TTM value through Mar 2026 reached $1.0 billion, up 12.98%, while the annual FY2025 figure was $905.9 million, 2.14% up from the prior year.
  • Current Assets hit $1.0 billion in Q1 2026 for Encompass Health, up from $905.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.0 billion in Q2 2022 and bottomed at $717.2 million in Q4 2022.
  • Average Current Assets over 5 years is $882.2 million, with a median of $905.9 million recorded in 2025.
  • Year-over-year, Current Assets decreased 22.16% in 2022 and then increased 22.07% in 2024.
  • Encompass Health's Current Assets stood at $717.2 million in 2022, then grew by 17.37% to $841.8 million in 2023, then rose by 5.36% to $886.9 million in 2024, then grew by 2.14% to $905.9 million in 2025, then grew by 13.6% to $1.0 billion in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $1.0 billion, $905.9 million, and $869.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.